Monday, April 6, 2015 (HealthDay News)-A new breath test approved by the U.S. Food and Drug Administration to help doctors diagnose the following conditions: Gastroparesis, Delayed excretion of gastric contents into the small intestine.
The FDA said in a news release on Monday that previous trials were more invasive and involved the use of small amounts of radioactive material. This required testing in a specialized outpatient facility.
The GEBT breath test, on the other hand, can be done in the clinic and lasts for 4 hours after an overnight fast. According to the FDA, doctors can determine how quickly the stomach empties solids by measuring the carbon dioxide content in a person’s breathing.
Gastroparesis It results from damage to the vagus nerve, which controls the muscles of the stomach and small intestine.It can occur among diabetics after gastrointestinal surgery HyperglycemiaAs a result of neurological conditions such as, or Parkinson’s disease Or Multiple sclerosisSaid the agency.
The new test was compared to the old diagnosis among 115 clinical trial participants. According to the FDA, the accuracy of the GEBT test ranges from 73% to 97%, depending on when the measurements were taken during the four hours.
The new test is manufactured by Advanced Breath Diagnostics, based in Brentwood, Tennessee.
Copyright © 2015 Health Day. all rights reserved.
New tests help diagnose delayed emptying of the stomach
Source link New tests help diagnose delayed emptying of the stomach